These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9383367)

  • 1. Engineering an interfacial zinc site to increase hormone-receptor affinity.
    Matthews DJ; Wells JA
    Chem Biol; 1994 Sep; 1(1):25-30. PubMed ID: 9383367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites.
    Kinet S; Bernichtein S; Kelly PA; Martial JA; Goffin V
    J Biol Chem; 1999 Sep; 274(37):26033-43. PubMed ID: 10473550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc mediation of the binding of human growth hormone to the human prolactin receptor.
    Cunningham BC; Bass S; Fuh G; Wells JA
    Science; 1990 Dec; 250(4988):1709-12. PubMed ID: 2270485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of receptor-specific variants of human growth hormone.
    Cunningham BC; Wells JA
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3407-11. PubMed ID: 2014261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis and protein engineering of receptor-binding determinants in human placental lactogen.
    Lowman HB; Cunningham BC; Wells JA
    J Biol Chem; 1991 Jun; 266(17):10982-8. PubMed ID: 2040614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis for growth hormone-receptor interactions.
    Wells JA; Cunningham BC; Fuh G; Lowman HB; Bass SH; Mulkerrin MG; Ultsch M; deVos AM
    Recent Prog Horm Res; 1993; 48():253-75. PubMed ID: 8441850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering human prolactin to bind to the human growth hormone receptor.
    Cunningham BC; Henner DJ; Wells JA
    Science; 1990 Mar; 247(4949 Pt 1):1461-5. PubMed ID: 2321008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines.
    Fuh G; Wells JA
    J Biol Chem; 1995 Jun; 270(22):13133-7. PubMed ID: 7768908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different elements of mini-helix 1 are required for human growth hormone or prolactin action via the prolactin receptor.
    Peterson FC; Brooks CL
    Protein Eng Des Sel; 2004 May; 17(5):417-24. PubMed ID: 15252206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a model to understand prolactin and growth hormone specificities.
    Goffin V; Martial JA; Summers NL
    Protein Eng; 1995 Dec; 8(12):1215-31. PubMed ID: 8869634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone binding to cultured human breast cancer cells.
    Murphy LJ; Vrhovsek E; Sutherland RL; Lazarus L
    J Clin Endocrinol Metab; 1984 Jan; 58(1):149-56. PubMed ID: 6315757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a second receptor binding site on human prolactin.
    Goffin V; Struman I; Mainfroid V; Kinet S; Martial JA
    J Biol Chem; 1994 Dec; 269(51):32598-606. PubMed ID: 7798264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sites.
    Schiffer C; Ultsch M; Walsh S; Somers W; de Vos AM; Kossiakoff A
    J Mol Biol; 2002 Feb; 316(2):277-89. PubMed ID: 11851338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The X-ray structure of a growth hormone-prolactin receptor complex.
    Somers W; Ultsch M; De Vos AM; Kossiakoff AA
    Nature; 1994 Dec; 372(6505):478-81. PubMed ID: 7984244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional binding epitope of a high affinity variant of human growth hormone mapped by shotgun alanine-scanning mutagenesis: insights into the mechanisms responsible for improved affinity.
    Pal G; Kossiakoff AA; Sidhu SS
    J Mol Biol; 2003 Sep; 332(1):195-204. PubMed ID: 12946357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of growth hormone bioactivity by zinc in the eluted stain assay system.
    Dattani MT; Hindmarsh PC; Brook CG; Robinson IC; Weir T; Marshall NJ
    Endocrinology; 1993 Dec; 133(6):2803-8. PubMed ID: 8243307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors.
    Untergasser G; Rumpold H; Hermann M; Dirnhofer S; Jilg G; Berger P
    Exp Gerontol; 1999 Apr; 34(2):275-87. PubMed ID: 10363793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based design of prolactin receptor antagonists.
    Fuh G; Colosi P; Wood WI; Wells JA
    J Biol Chem; 1993 Mar; 268(8):5376-81. PubMed ID: 8449901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting high-affinity binding proteins by monovalent phage display.
    Lowman HB; Bass SH; Simpson N; Wells JA
    Biochemistry; 1991 Nov; 30(45):10832-8. PubMed ID: 1932005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimerization of human growth hormone by zinc.
    Cunningham BC; Mulkerrin MG; Wells JA
    Science; 1991 Aug; 253(5019):545-8. PubMed ID: 1907025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.